Uniting to address paediatric heart disease in Africa: Advocacy from Rwanda by Binagwaho, Agnes et al.
440
countries in Africa are now addressing complex chronic diseases 
that have not previously been confronted, including cardiovascular 
diseases which require not only robust and integrated health care 
delivery platforms but also highly specialised care. In this article 
authors present the case of Rwanda as an example of a low-income 
country committed to establishing programmes to tackle the 
burden of paediatric heart disease.
Fifteen million children around the world die or are disabled each 
year due to heart disease.(1) Rheumatic heart disease, a clinical 
sequelae of inadequately-treated group A streptococcal throat 
infection, kills up to 345 110 people every year,(2) and remains one 
of the largest preventable burdens of disease in the world.(3-5)  
Endomyocardial fibrosis (EMF) also takes a massive toll on the poor 
living along the equator, though research has been sparse since its 
discovery in 1947 and the cause of EMF remains unknown.(6-8)  Up 
to 50% of children born with congenital heart defects in poor 
countries will succumb within the first month of life.(9)
Low- and middle-income countries bear 80% of the burden of 
heart disease,(10) despite the fact that most types of heart disease 
are preventable or highly treatable with the appropriate tools and 
training. Even children born with congenital heart disease, when 
detected and treated early, can often make a full recovery. And yet, 
despite major advances in scientific knowledge and clinical tech-
niques that have increased preventive, diagnostic and treatment 
INTRODUCTION
Across the African continent countries have made significant gains 
in improving child survival by controlling infectious diseases, up-
grading national immunisation programmes and expanding access 
to maternal, neonatal and basic primary health care. As the 
international community considers setting new global and national 
targets for reducing child mortality in the post-2015 development 
agenda, strengthening entire national health systems – including 
human resource capacity, infrastructure, access to medicines and 
information systems – is the paramount priority. Indeed, many 
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ABSTRACT
COMMENTARY
Paediatric heart disease causes death or disability in 15 
million children around the world each year – a fi gure 
staggeringly disproportionate to available and relevant 
international funding and support. Although 80% of the 
burden of cardiovascular disorders fall in low- and middle-
income countries, poor countries have a very limited capa-
city to build a system of care to address heart disease, 
including prevention, care, control and research. In this 
article, authors who work in or with Rwanda’s public sector 
aim to describe the current state of heart disease among 
children, what is currently being done to manage care and 
future directions for the national programme. As the world 
turns its attention to non-communicable diseases and seeks 
to ensure that they fi nd a prominent place in the post-2015 
development agenda, it is essential to ensure that children 


















options in wealthy countries in recent decades, a lack of access 
to up-to-date information, specialised clinicians and adequate 
resources in settings with the largest burdens of disease widens and 
entrenches disparities in risk and outcome. Indeed, about 4 000 
cardiac units existed in 2002, but served a mere 7% of the world’s 
population.(11)
THE RWANDAN CONTEXT
Rwanda is a small, landlocked, low-income country in East Africa, 
with a population of 10.5 million(12) and a gross national income 
per capita of $570.(13) Mortality attributable to HIV, tuberculosis, 
malaria and other causes of preventable child and maternal death 
declined precipitously over the past decade.(14) Deaths among 
children under the age of 5, for instance, have declined by 70.4% 
from 2000 to 2011, falling from 183 per 1 000 live births in 2000 
to 54.1 in 2011.(15) While Rwanda’s life expectancy was the lowest 
in the world throughout most of the 1990s, Rwandans born today 
can expect to live until at least 56 years. 
Health insurance coverage is near universal: the vast majority of 
Rwandans are enrolled in public (92%) or private health insurance 
(6%). The 1994 genocide that decimated the population also 
impacted upon the number of health care workers. But despite 
persistent gaps, the health workforce has now grown to a cadre of 
625 physicians, 8 513 nurses and 240 midwives who provide care 
in the country’s mostly new or rebuilt 42 decentralised hospitals 
and 473 health centres. Nearly 45 000 community health workers 
are elected as volunteers and trained in health promotion as well, 
thus providing basic diagnosis and treatment in Rwanda’s 15 000 
villages. Strong partnerships have been formed with non-govern-
mental and international organisations in recent years.
In 2009, the Government of Rwanda incorporated non-communi-
cable diseases (NCDs) into its Economic Development and Poverty 
Reduction Strategy as a “cross-cutting development issue,” man-
dating that each sector of government devise a strategic plan for 
contributing to the national response to the mounting burden of 
heart disease, cancer, diabetes, chronic respiratory conditions and 
major mental illness. The Ministry of Health has worked with 
partners to prepare its health system for a changing demographic 
and epidemiologic profile, including a growing prevalence of 
cardiovascular conditions across age groups. 
During the first decade of the national response to HIV/AIDS, 
Rwanda’s health authorities discovered that unless new programmes 
are designed with the unique vulnerabilities and needs of children 
in mind, challenges of linkage to care and retention quickly lead to 
children being left behind.(16) The Ministry of Health has therefore 
endeavored to ensure that new efforts to expand cardiac care 
capacity in Rwanda prioritise the needs of paediatric patients. 
Although research is scant and programmes limited, this article aims 
to capture the current state of Rwanda’s response to paediatric 
cardiac diseases and disorders, with a focus on congenital heart 
disorders and rheumatic heart disease, and to offer recommendations 
for the near future.
CONGENITAL HEART DISEASE
Most congenital cardiac diseases arise as early presentations. 
Common symptoms may include cyanosis, dyspnea, hepatomegaly, 
diaphoresis, feeding intolerance and failure to thrive. A minority of 
cases remains undetectable or asymptomatic through infancy and 
later manifest during adolescence or young adulthood. The key to 
survival in most cases however is early detection and intervention 
within the first year of life, particularly in cases of heart defects with 
significant left to right shunt. Diagnosis and treatment for congenital 
cardiac disease has undergone impressive evolution over the past 
few decades, with a noticeable shift from efforts to decrease post-
operative mortality to those emphasising improved quality of life 
and decreased morbidity. For example, the advent of sophisticated 
screening and detection options has now made the diagnosis of 
many defects possible “in utero”, allowing children born with con-
genital heart disease to undergo timely intervention and lead 
normal lives. 
Availability of modern scientific and technological advances, how-
ever, is largely limited to children born in high-income countries 
(and even then access is stratified according to family income level, 
insurance coverage and access or proximity to the right tertiary 
facility, among other factors). Late presentation or poor detection 
of congenital heart defects, as well as co-morbid conditions, 
deepens these inequities. Even the most basic diagnostic tools – 
pulse oximetry use in neonatal care and x-ray, echocardiography 
and electrocardiography (ECG) – are not available in public facilities 
in many low- and middle-income countries. In-service training for 
cardiovascular care is also sparse. Such inequitable distribution of 
science, training, equipment and financial resources results in 
hundreds of thousands of unnecessary deaths among children born 
with congenital heart disease each year in the poorest countries.
In Rwanda, the Ministry of Health’s 2012 Clinical Treatment 
Guidelines for Paediatrics include a thorough section on case 
detection for congenital heart disease. These guidelines are for 
outpatient diagnosis (passive case-finding) and inpatient care, as 
standard cardiovascular investigations are not yet conducted as part 
of routine neonatal or paediatric care. While most hospitals have 
x-ray capacity, echocardiography and ECG are only consistently 
available at 3 tertiary care facilities, all located in 2 main cities, Kigali 
and Butare. Treatment options are few in Rwanda: the population 
of children with congenital heart disease diminishes as the cohort 
ages secondary to mortality associated with their underlying 
condition. A small number (<40) of paediatric heart surgeries are 
performed each year by visiting foreign teams. One important step 
towards preventing congenital heart disease is the nationwide 
rollout of the rubella vaccine in March 2013, which will undoubtedly 
eventually reduce the burden of paediatric cardiac disease related 
to maternal rubella infection.
While plans to develop a national registry for congenital and 
acquired heart disease are in progress, the only data currently 
available for review is derived from intake records of one of 
Rwanda’s 2 paediatric cardiologists, who serve in Kigali University 
Teaching Hospital (KUTH), a public referral facility. Between 2010 
and 2013, a total of 321 patients were diagnosed with congenital 
heart disease at KUTH. Among these patients, 218 were aged 
5 years or younger, illuminating – if anecdotally – the need for early 
cardiac intervention. Forty-eight patients presented with Trisomy 
21, or Downs Syndrome, in addition to one or multiple congenital 
heart disorders, such as atrio-ventricular septal defect (often 
presenting as endocardial cushion defect), patent ductus arteriosus 
and tetralogy of fallot. About half of the cases were referred from 
locations within Kigali City Province, or from districts immediately 
adjacent to Kigali City Province in one of Rwanda’s other 4 
provinces. Given that population distribution in Rwanda is fairly 
even across provinces, these data provide clear messages about the 
need for clinical outreach to rural areas. 
After symptom onset and diagnosis, case management is often 
commenced at KUTH before patients are referred to district 
hospitals closer to home for follow-up. Most families pay for 10% of 
inpatient and outpatient care (for any disease, not just heart 
disease) under the community-based health insurance scheme; the 
poorest 25% of the population do not pay for care for any health 
issue. Essential medicines for congenital heart disease are available 
to patients with maximum 10% co-pay and include lasix, captopril, 
iron supplement, propanolol, aldactone, digoxin, sodium bicarbo-
nate and morphine. Some of these drugs are given within the 
hospital setting, others are prescribed and taken at home. Oxygen 
delivered by mask is not consistently available for all children in 
need at all district-level facilities, though the Ministry of Health 
considers this a priority area for improvement. As with all chronic 
diseases, it is just as “essential” that the patient be provided with 
adequate nutritional support in order for treatment to be deemed 
successful, though many public facilities in Rwanda do not provide 
food to patients. Finally, especially given the limited options for 
surgical intervention for children born with heart disease in Rwanda, 
access to medicines for palliative care is critical. Drugs for pain 
alleviation, including morphine, paracetamol, codeine and pethidine, 
are available at all district and referral hospitals and efforts to 
expand supply chains and training to health centres and communities 
are underway. Multiple drugs – either for the management of 
dyspnea or other associated heart failure complications – are 
available at district and referral hospitals. 
The majority of congenital heart disorders can be treated with 
significant relief of symptoms with cardiac surgery, if not cured. 
Survival is often predicated upon carefully planned, staged pro-
cedures with lifelong monitoring and follow-up care. For all cardiac 
surgical procedures among children with congenital heart disorders, 
a specialised level of expertise is required beyond that of routine 
cardiac surgery capabilities. Apart from a few centres performing 
neonatal cardiac surgery in northern and southern Africa, cardiac 
surgery is not available to the rest of the continent. Most affected 
babies will die in the first month or year of life or become inoperable 
for different reasons. For Rwanda and other countries without a 
domestic cardiac surgery programme, there arises the harsh reality 
of rationing the opportunity to receive life-saving cardiac surgery 
when available by visiting teams or by international referral. This 
selection is taxing on all involved, as the number of critical cases 
that require immediate surgical intervention always exceeds 
available resources.
ACQUIRED CARDIAC DISEASE
Although many diseases are considered acquired heart disorders 
among children, the authors present the case of rheumatic heart 
disease (RHD) in Rwanda given the availability of data and the high 
burden of disease. Beginning as a seemingly innocuous sore throat, 
the prequel of RHD is a common infection with the streptococcal 
antigen (group A streptococcal bacteria), usually among children 
and young adults. As many as 3% of children who develop strepto-
coccal infection in the throat and go untreated (with penicillin), 
will develop acute rheumatic fever affecting the body’s connective 
tissues – especially those of the heart, joints, brain or skin.(17) 
Around half of patients with acute rheumatic fever present with 
cardiac inflammation, mainly involving the valvular endocardium. 
Although the initial attack can lead to severe valvular disease, RHD 
most often results from cumulative valve damage due to recurrent, 
symptomatic or minimally-symptomatic episodes of acute rheumatic 
fever, which is often not associated with symptomatic pharyngitis 
and suggests that it might be insidious at onset.
One key challenge in addressing RHD lies in the lack of reliable data 
capturing the true burden of disease – i.e. precise geographical, age 
and gender distribution and health systems measurements such as 
where and when care is being sought, by whom and at what cost. 
Health authorities in many countries rely on regional estimates of 
the burden of RHD given the absence of national disease registries 



















and underreporting or misdiagnosing of acute and chronic cases of 
RHD.(18)  While some countries have executed robust screening 
and treatment programmes specific to RHD,(19-21) few structured 
national programmes for RHD prevention and care have been 
documented in resource-poor countries given limited funding, 
research capacity and adequate skill level and mix of health workers. 
Lack of adequate training or fear that a patient may have a fatal 
allergy to penicillin on the part of the health professionals may also 
influence care delivery.
Approximately 1 188 000 disability-adjusted life years (DALYs) are 
lost to RHD in sub-Saharan Africa, with a rate of roughly 138.3 per 
100 000 population.(22) The Global Burden of Disease 2010 study 
provides crude modeled estimates of the burden of RHD and 
other cardiac conditions in Rwanda, though none of the weak 
underlying data on which these are based were actually collected in 
East Africa. Despite the paucity of data, anecdotally, Rwanda’s 2 
paediatric cardiologists are noting an increase in clinical presentations 
of critical or late-stage RHD among their paediatric population. It 
may be the case that this upsurge is in part due to the improvements 
in Rwanda’s health system and health insurance coverage over 
recent years, in which patients can more easily than ever before be 
referred up to higher levels of care. Further research is required to 
better understand this relationship. 
The highest level of consistently available in-country care, however, 
is still medical intervention. In the same 2010 - 2013 database 
created by the paediatric cardiologists, 96 patients were diagnosed 
with acquired heart disease (AHD) and 66 of those patients had 
rheumatic heart disease. The majority of patients with AHD were 
girls (60 versus 36), and the average patient age was 12 years. Two 
cases were diagnosed as endomyocardial fibrosis (EMF) and 27 
others with other heart diseases (e.g. dilated cardiomyopathies 
and pericardial diseases among others). Among those children 
with RHD, more than half of all cases occurred in 12 - 16 year-old 
children.
Recognition of pre- and early rheumatic heart disease remains a 
major impediment to care delivery, as family members, teachers, or 
even clinicians may not know or consistently associate symptoms 
of streptococcal throat infection with a potentially fatal disease, 
especially when a child recovers without any or any significant 
treatment. Further, given that there are not yet consistent school 
health programmes nor annual check-ups for healthy children in 
Rwanda, it is more likely that the child would come for a visit if 
symptoms persisted for longer than would be considered a normal 
duration. Broad-reaching sensitisation programmes regarding strep 
throat infection and linkages to cardiac disease so far do not exist 
in Rwanda. 
A second missed opportunity in diagnosis occurs when symptoms 
of rheumatic fever and RHD (e.g. fatigue, malaise, repeated chest 
infections and fevers) are not immediately associated with 
compromised cardiac function. Those patients that do present with 
symptoms and are diagnosed with RHD are often beyond medical 
management and often require urgent, if not emergency, surgical 
therapy. Out-of-pocket payments for emergency medical attention, 
lengthy hospital stays, and lifelong warfarin therapy are additional 
barriers to care – even with national health insurance covering 90% 
or more of the costs. Furthermore, some parents of patients with 
RHD report having first sought care from traditional healers – 
though this care-seeking behaviour requires further research. 
Although traditional medicine in Rwanda is regulated and monitored 
by the Ministry of Health, any delays in seeking medical care further 
diminishes the patient’s chance of survival.
For most children who develop RHD – as for those born with 
congenital heart disease – surgery represents the only option for 
survival. Over the past several years, the health sector in Rwanda 
has relied upon a combination of strategies to address the need for 
cardiac surgery while the country strengthens its own human 
resources and infrastructure capacity for these types of inter-
ventions. Rwanda has been able to augment the surgical care 
provided for paediatric cardiac disease through a unique partnership 
between the Rwanda Ministry of Health and 4 expatriate teams 
that now rotate in-country on a consistent basis, providing cardiac 
surgery for paediatric and adolescent cases (Panel 1). Each team, 
representing a breadth of surgical expertise, has made important 
contributions to early steps in the establishment of training 
programmes for cardiac surgery, perfusion and cardiac nursing, 
among other specialisations. The unified goal of the teams is to 
provide care during visits and assist Rwanda towards establishing a 
self-sustaining, domestic, comprehensive cardiac programme and 
regional referral and training centre to address the surgical burden 
of paediatric cardiac disease. Recent media attention on RHD in 
Rwanda has also ushered in new international interest, rendering 
the country’s response to RHD even timelier.(23)
FUTURE DIRECTIONS
In order to mobilise resources and design effective interventions to 
address congenital and acquired heart disease in children, policy-
makers in Rwanda and across Africa need more and better data. 
Despite the fact that RHD is responsible for nearly 3 times the 
number of deaths caused by measles,(24) it is almost completely 
absent from the global health agenda, receiving just 0.07% of all 
global health research funding in 2009.(25) And while total deaths 
from RHD have declined around the world in recent decades, 
levels have remained constant in Africa,(26) meaning that disparities 
continue to grow as detection, care and treatment improve else-
where. Research is also needed to document the burden of 
congenital heart disease and all forms of acquired paediatric heart 
conditions beyond rheumatic disease. Assessing the effect on child 
health outcomes in Rwanda following the rubella vaccine rollout 
in March 2013 will also be important, as this type of public health 
intervention has the potential to improve the health of Rwanda’s 
citizens in the future. In order to accurately register and manage 
the burden of disease, more physician specialists in paediatric cardi-
ology are necessary. Furthermore, the tools and equipment for 
early detection and proper diagnosis, treatment and follow-up of 
cases are critical to advancing this national programme. Digital 
infrastructure for recording and follow-up of heart disease 
patients – similar to Rwanda’s national HIV/AIDS informatics 
system, TRACnet(27) – would lessen the time between research 
and action and improve longterm prognoses, particularly for RHD 
patients.
Beyond studies on prevalence and incidence, another research 
priority – under the categorisation of implementation science – 
relates to the care pathway for paediatric heart disease in Rwanda. 
In order to establish new programmes, the health sector would 
need to document the following: (1) the currently accessible care 
pathway for publicly insured patients in both rural and urban areas 
and the pathways taken by those who are uninsured, (2) the 
pathway patients and their parents are taking in reality (including 
the involvement of traditional healers) and (3) where patients are 
falling off the continuum of care. This type of health care delivery 
research would enable the Ministry of Health and its affiliated 
institutions to establish a care delivery value chain that responds to 
the population. 
From a programme intervention standpoint for rheumatic heart 
disease, primary and secondary prevention are priority areas for 
Rwanda. The prevention of streptococcal throat infection by 
improving living standards and decreasing overcrowding at the 
household level is in line with Rwanda’s Economic Development 
and Poverty Reduction Strategy. For secondary prevention, the 
health sector should focus on removing barriers to accessing 
penicillin prophylaxis. Research would inform which barriers to 
prioritise, however, this would most likely include sensitisation 
campaigns directed at the population (i.e. families, teachers, local 
authorities, community health workers, traditional healers) on the 
dangers of inaction. This would likely include reducing the time 
from symptom onset to treatment by examining barriers to 
accessing medicines.
Case finding is interrelated to all the aforementioned factors and 
would include improvements in timely recognition and referral of 
congenital and acquired heart disease (including early signs and 
symptoms of rheumatic fever) by nurses and physicians. Clinical 
knowledge advancements would call for continuing professional 
development courses offered to both physicians and nurses, and 
could be coupled with Rwanda’s new partnership with 23 American 
academic institutions to significantly enhance human resources for 
health in Rwanda.(28) Various innovations in technology for medical 
education and consultations between clinicians should also be 
pursued where most needed. The health sector may also consider 
echocardiography- or pulse oximetry-based screening in schools, 
hospitals or clinics in the early stages of developing its paediatric 
heart disease programme. One of the expatriate surgical teams, 
Team Heart, from Boston, USA, in partnership with the Rwanda 
Heart Foundation, carried out the first echo-based RHD screening 
of 2 693 school-aged children (6 - 16 years) in 10 randomly selected 
schools in the Gasabo District near Kigali in September 2011. Such 
studies can pave the way toward strengthening the national 
response.
CONCLUSION
Rwanda’s health sector already has a history of commitment to 
ensuring chronic care at the community-level.(29) Buttressing that 
system to incorporate care for paediatric heart disease would 
provide more ways for children who have undergone cardiac 
interventions to live long and healthy lives. At the moment, cardiac 
surgery is being performed both in Rwanda, led by foreign teams, 
and outside of the country. The teams that perform surgery in-
country have sought to strengthen capacity among Rwandan 
colleagues, though systematic advances are long overdue. A fully 
functioning cardiac surgical centre in Rwanda, run by highly trained 
cardiac surgery teams is a major goal of the programme. One 
Rwandan physician is currently a cardiac surgery resident outside 
of the country and there is reason to be optimistic that the creation 
of such a centre is in the near future. The full components of a 
cardiac surgery team (surgeons, cardiologists, anesthetists, nurses, 
perfusionists and so forth) will also be critical to establishing a 
cardiac surgery centre in Rwanda. Authors of a recent article stated 
that one centre for every one million people would be required to 
handle the burden of cardiac diseases around the world, most of 
which are currently neglected in global funding priorities.(30) Post-
operative care would be a vital component of a cardiac surgery 
centre, as well as close monitoring of procurement and supply 
chains, as is routine already.
As the world turns its attention to non-communicable diseases and 
seeks to ensure they find a prominent place in the post-2015 
development agenda,(31) it will be essential to ensure that children 
are not left behind. Paediatric cardiac diseases constitute a growing 
burden of preventable and highly treatable morbidity and mortality 
in many regions including Africa, and an agenda focused primarily 
on behavioural risk factors like smoking and diet will not meet the 
needs of affected children and families. Data on children’s access to 
antiretroviral therapy (28%) compared to adults’ (53%) around the 



















world(32) provide a sobering reminder of the consequences when 
systems are not explicitly designed with children’s vulnerabilities in 
mind. The global health community now faces an opportunity and 
a responsibility to guarantee that equitable and effective approaches 
to addressing paediatric cardiac diseases are a key part of efforts 
to fulfill the unfinished promise of the fourth Millennium Develop-
ment Goal.
PANEL 1:  PAEDIATRIC CARDIAC INTERVENTIONS 
IN RWANDA:  THE EXPERIENCE OF PARTNERS
Chain of Hope (Belgium)
Chain of Hope (COH) is a non-governmental, humanitarian 
organisation based in Brussels, Belgium which was founded in 1997. 
The goals of COH are to provide surgical services for children, 
transfer skills to local teams and assist in infrastructure planning. 
After a first visit by a Rwandan physician in 2004, COH has since 
hosted 2 cardiologists, one anaesthetist and one intensive care 
physician for 2-year fellowships in Belgium. Since 2007, over the 
course of 14 visits, COH partnered with the Ministry of Health of 
Rwanda to diagnose 320 children, perform cardiac catheterisation 
on 79 children (a technique used for the first time in Rwanda)(33) 
and provide surgical treatment to 23 children. The COH team 
generally includes 2 people for evaluation and diagnosis, and 6 - 10 
people for interventions, staying about one week in Rwanda and 
working with local personnel. Regular visits each year by all partner 
teams have initiated a dynamic process of cardiac care in Rwanda 
and stimulated the upgrade of equipment available. Partnerships 
have enabled foreign teams to work toward a shared end goal with 
the Ministry of Health: for Rwanda to have a self-sustaining 
programme addressing paediatric cardiac disease.
Healing Hearts Northwest (USA)
The first surgical experience of Healing Hearts Northwest took 
place in 2010 and surgical visits in 2011 and 2012 have followed. 
The team has served 50 patients during this time, including approx-
imately 8 congenital cases, one pericardiectomy and the remainder 
chiefly patients suffering from rheumatic heart disease. There have 
been significant gains in the knowledge and capabilities of the 
Rwandan counterparts, with an increasing percentage of care pro-
vided by Rwandan nurses. Likewise substantial knowledge and skills 
have been demonstrated by a Rwandan cardiac anesthesiologist 
and pump technician. Even with excellent progress having been 
made towards building an independent, domestic programme, chal-
lenges continue including retaining the individuals who develop 
these skills locally and establishing a reliable infrastructure support 
with regards to local purchasing of supplies and equipment mainte-
nance. Recognition of these challenges and embracing solutions will 
allow a fully functioning cardiac surgical centre in Rwanda to 
become not only a goal, but a fully fledged reality.
Operation Open Heart (Australia)
Operation Open Heart (OOH) commenced work in Rwanda in 
April 2006 at the invitation of the Rwandan Ministry of Health to 
assist in meeting the surgical needs of those suffering with congenital 
and rheumatic heart disease. From OOH’s inception in 1986, its 
goal has been to provide cardiac surgical services to countries 
where this service is not readily available while at the same time 
providing skills transfer and training to the local team, assisting also 
in infrastructure planning. The end goal being the creation of such 
a self-sustaining programme in Rwanda. The team of 35 - 40 
personnel visits Rwanda for a period of 17 days at a time, including 
periods for setup, patient screening, surgeries and post-operative 
care. While other visiting surgical teams to Rwanda are proficient 
in adult surgery, OOH has focused on paediatric needs and to-
date, after 6 visits to Rwanda, 136 children and adolescents have 
received surgical care.
Team Heart (Boston)
Team Heart (TH) is a non-governmental, humanitarian organisa-
tion based in Boston, Massachusetts. The TH Mission is the devel-
opment of a comprehensive programme to eradicate RHD. This 
includes annual trips to perform cardiac surgery on patients with 
advanced RHD (2008 - 2013; 86 patients operated), a screening 
programme (2011; ~2 800 school-aged children screened with 
echocardiography), education of Rwandan healthcare personnel 
(Rwandan surgeon training in South Africa; 2 trained perfusionists, 
one anesthesiologist, 10 - 20 nurses in and out of operating theatre 
trained and on site) and working with the Ministry of Health and 
Medical School of the National University of Rwanda to improve 
postoperative care for out patients. The ultimate goal is the 
establishment of a Rwandan-staffed hospital capable of providing 
comprehensive cardiac care for the people of Rwanda and 
surrounding countries.
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